ArticleThe Journal of investigative dermatology2013
Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa.
Article in The Journal of investigative dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- High cancer-associated mutational burden in normal blood of xeroderma pigmentosum group C, but not groups A, D, or F.Blood neoplasia · 2026Article
- Stem cell-based therapy for fibrotic diseases: mechanisms and pathways.Stem cell research & therapy · 2024Review
- Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your Eyes.Biomedicines · 2022Review
- Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.Pediatric research · 2018Review
- Current and Future Perspectives of Stem Cell Therapy in Dermatology.Annals of dermatology · 2017Review
- CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia.Stem cells and development · 2016Article
- CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa.NPJ Regenerative medicine · 2016Article
- From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.Molecular therapy : the journal of the American Society of Gene Therapy · 2015Review
- Transcriptional profiling of ectoderm specification to keratinocyte fate in human embryonic stem cells.PloS one · 2015Article
- The three-body problem of therapy with induced pluripotent stem cells.Genome medicine · 2015Article
- Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.Cold Spring Harbor perspectives in medicine · 2014Review
- Cell therapy in dermatology.Cold Spring Harbor perspectives in medicine · 2014Review
- [The many facets of inherited skin fragility].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2014Article
- Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa.The Journal of investigative dermatology · 2014Article
- Advances in understanding and treating dystrophic epidermolysis bullosa.F1000prime reports · 2014Review
- Processing of laminin α chains generates peptides involved in wound healing and host defense.Journal of innate immunity · 2014Article
- Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.Lancet (London, England) · 2013Review
- TALEN-based gene correction for epidermolysis bullosa.Molecular therapy : the journal of the American Society of Gene Therapy · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.